<?xml version="1.0"?>
 <template xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="openEHR/v1/Template">
   <id>2e8410e1-a318-4ced-92d6-9be38118de3f</id>
   <name>Fibrinolysis Protocol</name>
   <description>
     <lifecycle_state>Initial</lifecycle_state>
     <details>
       <purpose/>
       <use/>
       <misuse/>
     </details>
     <other_details>
       <item>
         <key>MetaDataSet:Sample Set </key>
         <value>Template metadata sample set </value>
       </item>
       <item>
         <key>Acknowledgements</key>
         <value/>
       </item>
       <item>
         <key>Business Process Level</key>
         <value/>
       </item>
       <item>
         <key>Care setting</key>
         <value/>
       </item>
       <item>
         <key>Client group</key>
         <value/>
       </item>
       <item>
         <key>Clinical Record Element</key>
         <value/>
       </item>
       <item>
         <key>Copyright</key>
         <value/>
       </item>
       <item>
         <key>Issues</key>
         <value/>
       </item>
       <item>
         <key>Owner</key>
         <value/>
       </item>
       <item>
         <key>Sign off</key>
         <value/>
       </item>
       <item>
         <key>Speciality</key>
         <value/>
       </item>
       <item>
         <key>User roles</key>
         <value/>
       </item>
     </other_details>
   </description>
   <annotations path="[openEHR-EHR-SECTION.adhoc.v1]">
     <items>
       <item>
         <key>Technical.ï»© Technical Traceability</key>
         <value>{~AHSID~2e8410e1-a318-4ced-92d6-9be38118de3f~NAME~Fibrinolysis Protocol}</value>
       </item>
     </items>
   </annotations>
   <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1 and name/value=&apos;Clinical Guidance&apos;]">
     <items>
       <item>
         <key>CKT.Content Details</key>
         <value>&lt;p&gt;ADULT - Fibrinolysis Protocol&lt;/p&gt;&lt;p&gt;Fibrinolysis is contraindicated in patients with uncorrected coagulopathy, recent CNS bleed, and sepsis with multisystem organ failure. Review chest x-ray prior to proceeding with fibrinolysis&lt;/p&gt;</value>
       </item>
     </items>
   </annotations>
   <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;alteplase Injection; 10 mg; intrapleural; every 12 hours; For 3 doses&apos;]/activities[at0001]">
     <items>
       <item>
         <key>CKT.Clinical Guidance</key>
         <value>&lt;p&gt;Adults: Recommended dosage is 10 mg of alteplase mixed in 30 mL of sodium chloride 0.9% injected via the chest tube following clamping followed by 5 mg of Dornase in 30 mL os sterile water injected via the chest tube following clamping. This can be repeated every 12 hours for 3 days.&lt;/p&gt;</value>
       </item>
       <item>
         <key>CKT.Content Details</key>
         <value>&lt;p&gt;Alteplase indication: other&lt;/p&gt;&lt;p&gt;Specify: Pleural effusion&lt;/p&gt;</value>
       </item>
     </items>
   </annotations>
   <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;dornase alpha Nebule 1mg/mL; 5 mg; intrapleural; every 12 hours; for 3 days&apos;]/activities[at0001]">
     <items>
       <item>
         <key>CKT.Clinical Guidance</key>
         <value>&lt;p&gt;Adults: Recommended dosage is 10 mg of alteplase mixed in 30 mL of sodium chloride 0.9%&amp;nbsp;injected via the chest tube following clamping followed by 5 mg of Dornase in 30 mL of sterile water injected via the chest tube following clamping. This can be repeated every 12 hours for 3 days.&lt;/p&gt;</value>
       </item>
     </items>
   </annotations>
   <definition xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" name="Fibrinolysis Protocol">
     <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
     <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="effaf25a-52f4-416e-8488-920790ebf4a1" concept_name="PHARM alteplase injection Order" max="1" path="/items" name="alteplase Injection; 10 mg; intrapleural; every 12 hours; For 3 doses"/>
     <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="THEN"/>
     <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="0d9719f2-8a3e-45ac-8d17-4ec4f6d3e8c4" concept_name="PHARM dornase alpha Nebule 1mg/mL Order" max="1" path="/items" name="dornase alpha Nebule 1mg/mL; 5 mg; intrapleural; every 12 hours; for 3 days"/>
   </definition>
   <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.adhoc.v1">
     <digest id="MD5-CAM-1.0.1">8AE70853975A75254E6D39A8DE3652AF</digest>
   </integrity_checks>
   <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1">
     <digest id="MD5-CAM-1.0.1">4B2F0F6CD593E442DA9C30277A3EA9CF</digest>
   </integrity_checks>
   <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1">
     <digest id="MD5-CAM-1.0.1">AD8DFB192E67715F0D9E11E95E674AD0</digest>
   </integrity_checks>
   <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.service_request_information.v1">
     <digest id="MD5-CAM-1.0.1">230A8D964017E1FD7AC82EBDEE0202A6</digest>
   </integrity_checks>
 </template>